WRBY Warby Parker Inc. Class A Common Stock

NYSE · US · Healthcare · Medical Instruments & Supplies · warbyparker.com

27.03USD-1.67%Mkt Cap: 3.34B $P/E: 450.503d ago

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polariz…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap3.34B USD

Enterprise Value3.30B USD

Revenue (TTM)911.61M USD

Gross Profit470.58M USD

Net Income (TTM)1.64M USD

Revenue/Share7.39 USD

Last Price27.03 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees2.3K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)450.50

P/E (Forward)43.97

PEG—

EV/EBITDA79.57

EV/Revenue3.62

P/S3.67

P/B8.51

EPS (TTM)0.06

EPS (Forward)0.61

52W Range

14.9675% of range31.00

52W High31.00 USD

52W Low14.96 USD

Profitability

Gross Margin53.97%

Oper. Margin-3.60%

EBITDA Margin4.55%

Profit Margin0.19%

ROE0.45%

ROA0.23%

Growth

Revenue Growth9.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF110.78M USD

CapEx (TTM)67.05M USD

FCF Margin1.04%

FCF Yield0.29%

Net Debt-41.69M USD

Net Debt/EBITDA-1.01

Balance Sheet

Debt/Equity0.63

Current Ratio2.27

Quick Ratio1.80

Book Value/Sh3.18 USD

Cash/Share2.37 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)30.46 USD

Upside (mean)+12.7%

Target Range24.00 USD – 35.00 USD

24.00+12.7% to mean35.00

# Analysts13

Ownership

Shares Out.108.24M

Float94.60M

Insiders5.64%

Institutions116.65%

Short Interest

Short Ratio7.7d

Short % Float20.27%

Short % Out.14.26%

Shares Short17.62M

Short (prev mo.)18.12M

Technical

SMA 5025.64 (+5.4%)

SMA 20025.21 (+7.2%)

Beta1.91

S&P 52W Chg14.58%

Avg Vol (30d)3.01M

Avg Vol (10d)4.23M

Technical Indicators

RSI (14)56.5

MACD0.4684

MACD Signal0.0062

MACD Hist.+0.4622

BB Upper28.24 USD

BB Middle25.00 USD

BB Lower21.75 USD

BB Width25.97%

ATR (14)1.637 USD

Vol Ratio (20d)0.80x